chr12-12786943-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000356591.5(APOLD1):c.38G>T(p.Gly13Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,459,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000356591.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOLD1 | NM_030817.3 | c.38G>T | p.Gly13Val | missense_variant | 2/2 | ENST00000356591.5 | NP_110444.3 | |
APOLD1 | NM_001130415.2 | c.131G>T | p.Gly44Val | missense_variant | 2/2 | NP_001123887.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOLD1 | ENST00000356591.5 | c.38G>T | p.Gly13Val | missense_variant | 2/2 | 1 | NM_030817.3 | ENSP00000348998 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000501 AC: 3AN: 59844Hom.: 0 AF XY: 0.0000284 AC XY: 1AN XY: 35216
GnomAD4 exome AF: 0.0000520 AC: 68AN: 1307434Hom.: 0 Cov.: 31 AF XY: 0.0000466 AC XY: 30AN XY: 644244
GnomAD4 genome AF: 0.000538 AC: 82AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.131G>T (p.G44V) alteration is located in exon 2 (coding exon 2) of the APOLD1 gene. This alteration results from a G to T substitution at nucleotide position 131, causing the glycine (G) at amino acid position 44 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at